Table 3.
Adverse events
Variables | Control (n = 21) | Intervenção (n = 19) | p |
---|---|---|---|
Arrhitmia, n (%) | 3 (14.3) | 3 (15.8) | 1.000 |
Seizure, n (%) | 0 | 1 (5.3) | 0.475 |
Vomiting, n (%) | 2 (9.5) | 2 (10.5) | 1.000 |
Constipation, n (%) | 14 (66.7) | 13 (68.4) | 1.000 |
Cholestasis, agranulocytosis, thrombocytopenia, hepatitis and diplopia were not observed in any patients